Immunogenicity and Safety of <i>H influenzae</i> Type b–<i>N meningitidis</i> C/Y Conjugate Vaccine in Infants

Abstract

The HibMenCY was immunogenic against MenC and MenY and induced anti-polyribosylribitol phosphate antibody levels noninferior to those of licensed Hib conjugate vaccine. The safety profile of the HibMenCY was clinically acceptable and comparable to Hib conjugate vaccine.